Deganello A, Gitti G, Parrinello G, Muratori E, Larotonda G, Gallo O
Academic Clinic of Otolaryngology and Head-Neck Surgery, University of Florence, Italy.
Acta Otorhinolaryngol Ital. 2013 Dec;33(6):380-7.
Reconstructive surgery of the head and neck region has undergone tremendous advancement over the past three decades, and the success rate of free tissue transfers has risen to greater than 95%. It must always be considered that not all patients are ideal candidates for free flap reconstruction, and also that not every defect strictly requires a free flap transfer to achieve good functional results. At our institution, free flap reconstruction is first choice, although we use pedicled alternative flaps for most weak patients suffering from severe comorbidities, and for pretreated patients presenting a second primary or a recurrent cancer. From July 2006 to May 2010, 54 consecutive patients underwent soft tissue reconstruction of oral cavity and oropharyngeal defects. We divided the cohort in three groups: Group 1 (G1): 16 patients in good general conditions that received free radial forearm flap reconstruction; Group 2 (G2): 18 high-risk patients that received a reconstruction with infrahyoid flap; Group 3 (G3): 20 patients that received temporal flap (10 cases) or pectoral flap (10 cases) reconstruction. We must highlight that pedicled alternative flaps were used in elderly, unfavourable and weak patients, where usually the medical costs tend to rise rather than decrease. We compared the healthcare costs of the three groups, calculating real costs in each group from review of medical records and operating room registers, and calculating the corresponding DRG system reimbursement. For real costs, we found a statistically significant difference among groups: in G1 the average total cost per patient was € 22,924, in G2 it was € 18,037 and in G3 was € 19,872 (p = 0.043). The amount of the refund, based on the DRG system, was € 7,650 per patient, independently of the type of surgery. Our analysis shows that the use of alternative non-microvascular techniques, in high-risk patients, is functionally and oncologically sound, and can even produce a cost savings. In particular, the infrahyoid flap (G2) ensures excellent functional results, accompanied by the best economic savings in the worst group of patients. Our data reflect a large disconnection between the DRG system and actual treatment costs.
在过去三十年中,头颈部重建手术取得了巨大进展,游离组织移植的成功率已升至95%以上。必须始终考虑到,并非所有患者都是游离皮瓣重建的理想候选人,而且并非每个缺损都严格需要游离皮瓣移植才能获得良好的功能效果。在我们机构,游离皮瓣重建是首选方法,不过对于大多数患有严重合并症的体弱患者以及患有第二原发性癌或复发性癌的经预处理患者,我们会使用带蒂替代皮瓣。从2006年7月至2010年5月,连续54例患者接受了口腔和口咽缺损的软组织重建。我们将该队列分为三组:第一组(G1):16例一般状况良好的患者接受了游离桡侧前臂皮瓣重建;第二组(G2):18例高危患者接受了肩胛舌骨肌皮瓣重建;第三组(G3):20例患者接受了颞部皮瓣(10例)或胸大肌皮瓣(10例)重建。我们必须强调,带蒂替代皮瓣用于老年、情况不佳和体弱的患者,这些患者的医疗费用通常趋于上升而非下降。我们比较了三组的医疗费用,通过查阅病历和手术室记录计算每组的实际费用,并计算相应的疾病诊断相关分组(DRG)系统报销费用。对于实际费用,我们发现组间存在统计学显著差异:G1组每位患者的平均总费用为22,924欧元,G2组为18,037欧元,G3组为19,872欧元(p = 0.043)。基于DRG系统的报销金额为每位患者7,650欧元,与手术类型无关。我们的分析表明,在高危患者中使用替代非微血管技术在功能和肿瘤学方面是合理的,甚至可以节省成本。特别是,肩胛舌骨肌皮瓣(G2)确保了出色的功能效果,在最差的患者组中实现了最佳的经济节省。我们的数据反映了DRG系统与实际治疗成本之间存在很大脱节。